<qa>  What is the purpose of this study?The purpose of this study is to evaluate the antitumor activity of pazopanib in patients with metastatic andor locally advanced unresectable Gastrointestinal Stromal Tumors GIST resistant to imatinib and sunitinib. This is a phase II, randomized, multicentre study. 